Glycyrrhetinic acid

Glycyrrhetinic acid is a lipid of Prenol Lipids (PR) class. Glycyrrhetinic acid is associated with abnormalities such as Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency, Hypertensive disease, Mineralocorticoid Excess Syndrome, Apparent and Syndrome. The involved functions are known as Signal, Muscle Contraction, Pressure- physical agent, Agent and Metabolic Inhibition. Glycyrrhetinic acid often locates in Protoplasm, Body tissue, Muscle, Connexon and Extracellular. The associated genes with Glycyrrhetinic acid are SLC33A1 gene, GJB1 gene, RNU1-1 gene, HADHA gene and RNU1-4 gene. The related lipids are Steroids, Saponin, Octanols, Heptanol and amyrin.

Cross Reference

Introduction

To understand associated biological information of Glycyrrhetinic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glycyrrhetinic acid?

Glycyrrhetinic acid is suspected in Hypertensive disease, Kozlowski Celermajer Tink syndrome, Hypernatremia, Leishmaniasis, Visceral, Congenital Abnormality, Cortisol 11-beta-ketoreductase deficiency and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glycyrrhetinic acid

PubChem Associated disorders and diseases

What pathways are associated with Glycyrrhetinic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glycyrrhetinic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glycyrrhetinic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glycyrrhetinic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Glycyrrhetinic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glycyrrhetinic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Glycyrrhetinic acid

Download all related citations
Per page 10 20 50 100 | Total 1459
Authors Title Published Journal PubMed Link
Meek EM et al. Carbenoxolone and incorporation of (3H) glucosamine into gastric mucosa. 1978 Curr Med Res Opin pmid:710177
Beccari G et al. [Hypocalcemia during cimetidine and carbenoxolone treatment]. 1982 Minerva Med. pmid:7088404
Imagawa M et al. High renin low blood pressure and its treatment with calcium glycyrrhetinyl-glycinate. 1982 Jpn Heart J pmid:7043023
Cook PJ et al. Carbenoxolone (duogastrone) and cimetidine in the treatment of duodenal ulcer--a therapeutic trial. 1980 Scand. J. Gastroenterol. Suppl. pmid:7010531
Loginov AS et al. The effectiveness of carbenoxolone in the treatment of gastro-duodenal ulcer patients. 1980 Scand. J. Gastroenterol. Suppl. pmid:7010530
Schwamberger K and Reissigl H Carbenoxolone patients with gastric ulcers. A double-blind trial. 1980 Scand. J. Gastroenterol. Suppl. pmid:7010529
Reed PI et al. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial. 1980 Scand. J. Gastroenterol. Suppl. pmid:7010528
Schenk J et al. Controlled trial of carbenoxolone sodium vs. cimetidine in duodenal ulcer. 1980 Scand. J. Gastroenterol. Suppl. pmid:7010527
Monni S et al. [Clinical study of the effect of thiopropamine in duodenal ulcer pathology]. 1980 Clin Ter pmid:7009030
Krasova TG et al. [Hydrocortisone and prednisolone solubilization in aqueous solutions of glyciram]. 1978 Sep-Oct Farmatsiia pmid:700181
García Sacristán A [Pharmacological activity of various derivatives of glycyrrhetic acid]. 1978 Arch Farmacol Toxicol pmid:697383
Ishikawa S and Saito T The effect of glycyrrhetinic acid on the action of aldosterone in stimulating sodium transport in frog skin. 1980 Endocrinol. Jpn. pmid:6973465
Ganguli PC and Mohamed SD Long-term therapy with carbenoxolone in the prevention of recurrence of gastric ulcer. Natural history and evolution of important side-effects and measures to avoid them. 1980 Scand. J. Gastroenterol. Suppl. pmid:6937941
Wright PA et al. Serum carbenoxolone: ulcer-healing and metabolic effects. 1980 Scand. J. Gastroenterol. Suppl. pmid:6937940
Thornton PC et al. Carbenoxolone interactions in man--preliminary report. 1980 Scand. J. Gastroenterol. Suppl. pmid:6937939
Symons AM and Parke DV The effects of sodium carbenoxolone on the stability of cellular membranes. 1980 Scand. J. Gastroenterol. Suppl. pmid:6937938
Rees WD et al. Effect of carbenoxolone on alkaline secretion by isolated amphibian gastric and duodenal mucosa. 1981 Eur. J. Clin. Invest. pmid:6800823
Berndt H and Gütz HJ [Evaluation of carbenoxolone in long term treatment of recurrent duodenal ulcer (author's transl)]. 1981 Dtsch Z Verdau Stoffwechselkr pmid:6786855
Elder JB and Hearn AR Intragastric PCO2 in man and calculated gastric bicarbonate concentrations: effect of carbenoxolone sodium. 1980 Scand. J. Gastroenterol. Suppl. pmid:6782652
Roberts NB and Taylor WH The actions of carbenoxolone on enzymes and their relation to its therapeutic effect. 1980 Scand. J. Gastroenterol. Suppl. pmid:6782651
Kamei H and Arakawa K A case of pseudoaldosteronism due to addiction of Jintan, a mouth refresher popular among Japanese. 1982 Jpn Heart J pmid:6752476
Sticher O and Soldati F [Glycyrrhizic acid determination in Radix liquiritiae with high pressure liquid chromatography (HPLC)]. 1978 Pharm Acta Helv pmid:674237
Kellow JE Topical carbenoxolone therapy for acute stomatitis. 1984 Med. J. Aust. pmid:6738411
Sugimoto K et al. [A case report of hypokalemic myopathy due to ingestion of large doses of "jintan"]. 1984 Nippon Naika Gakkai Zasshi pmid:6726041
Kato E [Etiological studies of secondary hypertension. e. Drug-induced hypertension]. 1984 Nippon Rinsho pmid:6716694
Kiso Y et al. Assay method for antihepatotoxic activity using galactosamine-induced cytotoxicity in primary-cultured hepatocytes. 1983 Nov-Dec J. Nat. Prod. pmid:6677713
Baron JH Side-effects of carbonoxolone. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6673458
Reed PI et al. Comparative study of carbenoxolone and cimetidine in the management of duodenal ulcer. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6673457
Guslandi M Importance of defensive factors in the prevention of peptic ulcer recurrence. Role of carbenoxolone sodium. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6673456
Tárnok F et al. Effect of the combinations atropine + cyproheptadine and atropine + carbenoxolone in duodenal ulcer therapy. 1983 Int J Tissue React pmid:6654627
Komoda Y [Nuclear magnetic resonance spectra of 18-beta-glycyrrhetinic acid and its related compounds]. 1984 Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku pmid:6598495
Minuz P et al. Carbenoxolone and prostaglandin E2 and F2 alpha gastric juice levels in man. 1984 Pharmacol Res Commun pmid:6594711
Poswillo D and Partridge M Management of recurrent aphthous ulcers. A trial of carbenoxolone sodium mouthwash. 1984 Br Dent J pmid:6588992
Partridge M and Poswillo DE Topical carbenoxolone sodium in the management of herpes simplex infection. 1984 Br J Oral Maxillofac Surg pmid:6585224
Rask-Madsen J et al. Effects of carbenoxolone on gastric release of prostaglandin (PG)E2 in patients with peptic ulcer disease. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6585111
Louise F [Effect of glycyrrhetinic acid on the status of gingival health. Clinical study]. 1983 Inf Dent pmid:6582037
Akada Y et al. Rapid estimation of glycyrrhizin in pharmaceutical preparations by high-speed liquid chromatography. 1978 Chem. Pharm. Bull. pmid:657410
Corsini G et al. Sucralfate and carbenoxolone in the treatment of functional disturbances following partial gastrectomy. 1984 Int J Tissue React pmid:6547414
Amagaya S et al. Comparative studies of the stereoisomers of glycyrrhetinic acid on anti-inflammatory activities. 1984 J. Pharmacobio-dyn. pmid:6533282
Man WK et al. Effect of cimetidine and carbenoxolone on cysteamine-induced ulcers: a study of gastric mucosal histamine and histamine formation capacity in rat. 1984 Agents Actions pmid:6532172
Bennett A Gastric mucosal formation of prostanoids and the effects of drugs. 1984 Acta Physiol Hung pmid:6532116
Fuggersberger-Heinz R and Franz G Formation of glycyrrhizinic acid in Glycyrrhiza glabra var. typica. 1984 Planta Med. pmid:6522506
Kimura M et al. Blocking effects of blended paeoniflorin or its related compounds with glycyrrhizin on neuromuscular junctions in frog and mouse. 1984 Jpn. J. Pharmacol. pmid:6521072
Kiso Y et al. Mechanism of antihepatotoxic activity of glycyrrhizin. I: Effect on free radical generation and lipid peroxidation. 1984 Planta Med. pmid:6505079
Kitagawa K et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-stimulated 3-O-methyl-glucose transport in mouse Swiss 3T3 fibroblasts by glycyrrhetic acid. 1984 Cancer Lett. pmid:6478444
Roberts NB et al. The action of carbenoxolone on enzymes, with special reference to the pepsins and their secretion. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6424375
Rask-Madsen J et al. Effect of carbenoxolone on gastric prostaglandin E2 levels in patients with peptic ulcer disease following vagal and pentagastrin stimulation. 1983 Eur. J. Clin. Invest. pmid:6413222
Csonka GW and Tyrrell DA Treatment of herpes genitalis with carbenoxolone and cicloxolone creams: a double blind placebo controlled clinical trial. 1984 Br J Vener Dis pmid:6375805
Parke DV The biochemical pharmacology of carbenoxolone. Its possible mechanisms of action. 1983 Sep-Oct Acta Gastroenterol. Belg. pmid:6369855
Shakhnes IE [Use of glycyram in the treatment of dermatoses]. 1983 Vestn Dermatol Venerol pmid:6367265
Fujiwara Y et al. Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin. 1983 Endocrinol. Jpn. pmid:6357769
Vinogradov VA et al. [Use of the reglan test for the evaluation of the endocrine changes during treatment of duodenal ulcer with biogastron]. 1983 Ter. Arkh. pmid:6342195
Armanini D et al. Affinity of liquorice derivatives for mineralocorticoid and glucocorticoid receptors. 1983 Clin. Endocrinol. (Oxf) pmid:6315264
Ozeki T et al. The effects of hydrocortisone and glycyrrhizine on the enzyme releases of arylsulfatase and hyaluronidase from lysosomes of liver. 1978 Experientia pmid:631276
Hamill JJ Management of reflux oesophagitis. 1983 Practitioner pmid:6304672
Abe N et al. Interferon induction by glycyrrhizin and glycyrrhetinic acid in mice. 1982 Microbiol. Immunol. pmid:6290851
Armanini D et al. The mechanism of mineralocorticoid action of carbenoxolone. 1982 Endocrinology pmid:6290195
Markham C and Reed PI Pyrogastrone treatment of peptic oesophagitis: analysis of 104 patients treated during a 3 1/2-year period. 1980 Scand. J. Gastroenterol. Suppl. pmid:6259715
Williams JG and Croft DN Carbenoxolone and gastric Technetium-99m pertechnetate uptake in patients with gastric ulceration. 1980 Scand. J. Gastroenterol. Suppl. pmid:6259714
Peskar BM Effect of carbenoxolone on prostaglandin synthesizing and metabolizing enzymes and correlation with gastric mucosal carbenoxolone concentrations. 1980 Scand. J. Gastroenterol. Suppl. pmid:6259713
Yamashita S et al. [Clinical evaluation of a gingival massage agent (LPD) on gingivitis and marginal periodontitis using a double blind method]. 1984 Nihon Shishubyo Gakkai Kaishi pmid:6241219
Parodi MC et al. Influence of 'cytoprotective' drugs (carbenoxolone, zolimidine, prostanoic acid) on mucus secretion in patients with gastric ulcer. 1984 Scand. J. Gastroenterol. Suppl. pmid:6234649
Mooreville M et al. Enhancement of the bladder defense mechanism by an exogenous agent. 1983 J. Urol. pmid:6224942
Martin A et al. Effect of carbenoxolone on gastric prostaglandin E release and cytoprotection in the rat. 1983 Adv. Prostaglandin Thromboxane Leukot. Res. pmid:6221623
Strauss RJ et al. Prevention of stress ulcerations with cimetidine and carbenoxolone. 1977 Surg Forum pmid:617465
Guslandi M et al. Effect of carbenoxolone and cimetidine on gastric mucin. 1980 Clin Ther pmid:6157471
LaBrooy SJ Medical management of gastric ulcer. 1983 Ann. Acad. Med. Singap. pmid:6146287
Capasso F et al. Glycyrrhetinic acid, leucocytes and prostaglandins. 1983 J. Pharm. Pharmacol. pmid:6134809
Clavenna G et al. Antiulcer and mineralocorticoid activities of carbenoxolone and desoxycorticosterone in rats. 1982 J. Pharm. Pharmacol. pmid:6126564
Poswillo DE and Roberts GJ Topical carbenoxolone for orofacial herpes simplex infections. 1981 Lancet pmid:6113498
XI international congress of gastroenterology. Hamburg, FRG, Carbenoxolone symposium, June 1980. 1980 Scand. J. Gastroenterol. Suppl. pmid:6111118
Martin DF and Miller JP Relapsing ulcers and mucosal protecting agents. 1981 Lancet pmid:6110837
Makidono R et al. [Leukopenia and lymphopenia during the radiation therapy and their recovery by anti-leukopenia drugs (author's transl)]. 1977 Nihon Igaku Hoshasen Gakkai Zasshi pmid:609534
Tamura Y et al. Effects of glycyrrhetinic acid and its derivatives on delta 4-5 alpha- and 5 beta-reductase in rat liver. 1979 Arzneimittelforschung pmid:582760
Dajani EZ et al. Gastric antiulcer and antisecretory effects of carbenoxolone, aldosterone and desoxycorticosterone in rats. 1979 Arch Int Pharmacodyn Ther pmid:543742
Kadish U and Neeman A [Carbenoxolone in the treatment of duodenal ulcer]. 1979 Harefuah pmid:540839
Jones FA and Hunt T Drugs for peptic ulcer. 1979 World J Surg pmid:516781
Brailski Kh and Dimitrov B [Treatment of peptic ulcer with Biogastrone (carbenoxolone)]. 1979 Vutr Boles pmid:516651
Stadnicki A [Value of biogastrone and duodenal biogastrone in the treatment of peptic ulcer]. 1979 Pol Tyg Lek pmid:503921
Sakiya Y et al. Rapid estimation of glycyrrhizin and glycyrrhetinic acid in plasma by high-speed liquid chromatography. 1979 Chem. Pharm. Bull. pmid:498371
Simon B et al. [Treatment of cimetidine-resistant gastric ulcer with carbenoxolone-sodium (author's transl)]. 1979 Med Klin pmid:492046
Mourad G et al. [Rhabdomyolysis and acute renal insufficiency. Role of potassium depletion induced by a liquorice overdose]. 1979 Apr-May J Urol Nephrol (Paris) pmid:480434
Humphrey MJ et al. Effect of carbenoxolone on the concentrations of aldosterone in rat plasma and kidney. 1979 J. Endocrinol. pmid:469454
Kishi J [A study on the effects of additives in dentifrices in the prevention of periodontal diseases (author's transl)]. 1974 Koku Eisei Gakkai Zasshi pmid:4534641
Visconti GP et al. [Peptic ulcer: a social and therapeutic problem still current]. 1979 Recenti Prog Med pmid:42955
Habib AA et al. New and simple methylene blue colorimetric assay for glycyrrhizin in pharmaceuticals. 1979 J Pharm Sci pmid:41926
Kimura M et al. Decreasing effects by glycyrrhizin and paeoniflorin on intracellular Ca2+-aequorin luminescence transients with or without caffeine in directly stimulated-diaphragm muscle of mouse. 1985 Jpn. J. Pharmacol. pmid:4094183
Kobuke T et al. Tumorigenicity study of disodium glycyrrhizinate administered orally to mice. 1985 Food Chem. Toxicol. pmid:4076931
Gottfried S et al. A quantitative morphological study of the effects of carbenoxolone sodium on duodenal goblet-cells of the rat. 1985 Gen. Pharmacol. pmid:4018547
Kimura M et al. Depolarizing neuromuscular blocking action induced by electropharmacological coupling in the combined effect of paeoniflorin and glycyrrhizin. 1985 Jpn. J. Pharmacol. pmid:4010089
Gabor M [Treatment of ulcer with acetoxolon]. 1985 Dtsch. Med. Wochenschr. pmid:4006763
Masoero G [Controlled clinical study of the effectiveness of a new anti-ulcer drug: thiopropamine]. 1979 Clin Ter pmid:399873
Segal R et al. Anticariogenic activity of licorice and glycyrrhizine I: Inhibition of in vitro plaque formation by Streptococcus mutans. 1985 J Pharm Sci pmid:3981425
Barbara L et al. Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial. 1979 Scand. J. Gastroenterol. Suppl. pmid:396653
Kitagawa K et al. Inhibition of the specific binding of 12-O-tetradecanoylphorbol-13-acetate to mouse epidermal membrane fractions by glycyrrhetic acid. 1986 Oncology pmid:3951787
Davidson JS et al. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid. 1986 Biochem. Biophys. Res. Commun. pmid:3947327
Takeda R et al. Prolonged pseudoaldosteronism induced by glycyrrhizin. 1979 Endocrinol. Jpn. pmid:393503
Ishikawa S et al. Hypokalemic myopathy associated with primary aldosteronism and glycyrrhizine-induced pseudoaldosteronism. 1985 Endocrinol. Jpn. pmid:3914413
Bianchi Porro G et al. Comparison of pirenzepine and carbenoxolone in the treatment of chronic gastric ulcer. A double-blind endoscopic trial. 1985 Hepatogastroenterology pmid:3912314
Campisi D et al. Cytoprotective therapy of gastric ulcers: a controlled clinical evaluation of triletide versus carbenoxolone. 1985 Pharmatherapeutica pmid:3903785